Cartesian Therapeutics, Inc..
RNAC.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Cartesian Therapeutics, Inc. is a biotechnology company pioneering RNA cell therapy for autoimmune diseases. Their lead program, Descartes-08, is a potential treatment for myasthenia gravis and systemic lupus erythematosus. The company engineers patients' own T cells with RNA to target specific dise...Show More
Better Health for All
20
Cartesian Therapeutics' core business is dedicated to health improvement through RNA cell therapy for autoimmune diseases. Its lead product, Descartes-08, demonstrated exceptional health benefits in a Phase 2b clinical trial, with 83% of patients achieving a clinically meaningful response (at least a 2-point reduction in MG-ADL score), and 100% of patients without prior biologic therapy achieving this response.
1
As the company is in clinical development, it currently generates no revenue from commercial products, thus having no revenue from products with negative health outcomes. The safety record for Descartes-08 is perfect, with no new adverse events, cytokine release syndrome, or immune effector cell-associated neurotoxicity syndrome (ICANS) observed during the 12-month study.
2
The company also adheres to ethical guidelines for its clinical trials, obtaining IRB approval and documenting patient consent for its studies.
3
Fair Money & Economic Opportunity
0
No specific, concrete data points related to 'Fair Money & Economic Opportunity' were found for Cartesian Therapeutics, Inc. in the provided articles. explicitly states that no data is available for the company or the ethical value from the given URL.
1
Fair Pay & Worker Respect
0
No evidence available to assess Cartesian Therapeutics, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific, concrete data points regarding Cartesian Therapeutics, Inc.'s fair trade and ethical sourcing practices, supplier audits, child/forced labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend were found in the provided articles.
1
Honest & Fair Business
0
No evidence available to assess Cartesian Therapeutics, Inc. on Honest & Fair Business.
Kind to Animals
0
No evidence available to assess Cartesian Therapeutics, Inc. on Kind to Animals.
No War, No Weapons
0
No evidence was found in the provided articles to assess Cartesian Therapeutics, Inc. against any of the KPIs for the 'No War, No Weapons' ethical value. The articles describe the company's focus on mRNA cell therapies for autoimmune diseases, its terms of service, or general discussions on patenting dual-use technologies, none of which provide specific data points related to arms contracts, dual-use R&D, sales to sanctioned regimes, peacebuilding investments, or any other relevant metrics for this value.
Planet-Friendly Business
0
No relevant data was found in the provided articles to assess Cartesian Therapeutics, Inc. against the 'Planet-Friendly Business' ethical value. All articles either focused on unrelated topics or indicated that the requested pages were unavailable or not found, preventing the extraction of any specific, concrete facts regarding environmental performance, policies, or initiatives.
1
Respect for Cultures & Communities
0
No evidence available to assess Cartesian Therapeutics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
The company reports no incidents of unauthorized data use.
1
It conducts periodic risk and cybersecurity assessments to identify and monitor threats and mentions testing safeguards.
2
The company states compliance with U.S. and foreign regulations, including HIPAA and GDPR, and specifically mentions compliance with California Civil Code Section 1789.3.
3
Zero Waste & Sustainable Products
0
No evidence available to assess Cartesian Therapeutics, Inc. on Zero Waste & Sustainable Products.